Globus Medical, Inc.GMEDNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank95
3Y CAGR+179.6%
5Y CAGR+75.3%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+179.6%/yr
Quarterly compound
5Y CAGR
+75.3%/yr
Recent acceleration
Percentile
P95
Near historical high
vs 5Y Ago
16.6x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 94.18% |
| Q3 2025 | -4.72% |
| Q2 2025 | 20.85% |
| Q1 2025 | -1.04% |
| Q4 2024 | -5.57% |
| Q3 2024 | -6.15% |
| Q2 2024 | -34.17% |
| Q1 2024 | 9.60% |
| Q4 2023 | 78.16% |
| Q3 2023 | 37.39% |
| Q2 2023 | 1.26% |
| Q1 2023 | 8.07% |
| Q4 2022 | 4.31% |
| Q3 2022 | 7.51% |
| Q2 2022 | -0.10% |
| Q1 2022 | -65.87% |
| Q4 2021 | 221.84% |
| Q3 2021 | 1.97% |
| Q2 2021 | 4.17% |
| Q1 2021 | -2.08% |
| Q4 2020 | 5.69% |
| Q3 2020 | -63.45% |
| Q2 2020 | 156.17% |
| Q1 2020 | -0.61% |
| Q4 2019 | 6.81% |
| Q3 2019 | -7.86% |
| Q2 2019 | 9.93% |
| Q1 2019 | 4.11% |
| Q4 2018 | -11.39% |
| Q3 2018 | 14.82% |
| Q2 2018 | 6.57% |
| Q1 2018 | 11.18% |
| Q4 2017 | 4.83% |
| Q3 2017 | 1.62% |
| Q2 2017 | 0.44% |
| Q1 2017 | -21.82% |
| Q4 2016 | 32.91% |
| Q3 2016 | -3.11% |
| Q2 2016 | 5.62% |
| Q1 2016 | 1.97% |